By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Hemispherx Biopharma Inc. 

One Penn Center
1617 JFK Boulevard
Philadelphia  Pennsylvania  19103  U.S.A.
Phone: 215-988-0080 Fax: 215-988-1739


Company News
Hemispherx Biopharma (HEB) Fully Aligns Executive Bonus Programs To Accelerate Product Revenue Opportunities And Market Entry 8/31/2015 7:38:24 AM
Hemispherx Biopharma (HEB) Posts Photographs Of The Ampligen Facility In New Brunswick, New Jersey 8/27/2015 7:11:09 AM
Hemispherx Biopharma (HEB)'s Judgment Unanimously Affirmed Against Cato Capital 8/26/2015 8:20:32 AM
Hemispherx Biopharma (HEB) Hosts Stockholder Open House At Its Manufacturing And Research Development Center In New Jersey 8/26/2015 7:22:51 AM
Hemispherx Biopharma (HEB) Enters Into Direct Supply Agreement With Gulf Coast Regional Blood Center To Supply Leukocytes To Manufacture Alferon N Injection 8/24/2015 7:46:33 AM
Hemispherx Biopharma (HEB) Reminder Regarding Stockholder Open House At Manufacturing And Research Facility In New Jersey 8/19/2015 7:09:56 AM
Hemispherx Biopharma (HEB) Extends Its Strategic Alliance With Armada Health Care For Alferon N Injection 8/17/2015 6:51:55 AM
Hemispherx Biopharma (HEB) Announces Financial Results For The Six Months Ended June 30, 2015 8/13/2015 10:00:19 AM
Hemispherx Biopharma (HEB) Board Appoints New President 8/13/2015 7:49:59 AM
Hemispherx Biopharma (HEB) Expands Its Collaboration With Emerge Health For The Commercialization Of Alferon In Australia And New Zealand 8/11/2015 7:49:47 AM